Vanguard Group’s RenovoRx RNXT Stock Holding History
Bought
Maintained
Sold
Other funds holding RNXT
ACM
BL
WANY
CPIG
NPT
CG
Vanguard Group's RNXT Position: Q4 2025 in Review
Vanguard Group held its RenovoRx (RNXT) position steady in Q4 2025 at 1,605,079 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #3697.
Vanguard Group first reported a position in RNXT in Q1 2022 and has held it in 16 quarters since. The position peaked at $2.2M in Q2 2025. 33 funds tracked by Wall St. Rank hold RNXT as of Q4 2025.
- Vanguard Group held 1,605,079 shares of RenovoRx worth $1.35M as of Q4 2025.
- Vanguard Group left its RenovoRx share count unchanged in Q4 2025.
- RenovoRx made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3697 holding.
- Vanguard Group first reported a position in RenovoRx in Q1 2022 and has held it in 16 quarters since.
- Vanguard Group's RenovoRx position peaked at $2.2M in Q2 2025.
- 33 funds tracked by Wall St. Rank held RenovoRx as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.